These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 28249992)

  • 21. Adherence to statin therapy under drug cost sharing in patients with and without acute myocardial infarction: a population-based natural experiment.
    Schneeweiss S; Patrick AR; Maclure M; Dormuth CR; Glynn RJ
    Circulation; 2007 Apr; 115(16):2128-35. PubMed ID: 17420348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between in-hospital guideline adherence and postdischarge major adverse outcomes of patients with acute coronary syndrome in Vietnam: a prospective cohort study.
    Nguyen T; Le KK; Cao HTK; Tran DTT; Ho LM; Thai TND; Pham HTK; Pham PT; Nguyen TH; Hak E; Pham TT; Taxis K
    BMJ Open; 2017 Oct; 7(10):e017008. PubMed ID: 28982823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hospital revascularisation capability and quality of care after an acute coronary syndrome in Switzerland.
    Welker J; Auer R; Gencer B; Muller O; Cornuz J; Matter CM; Mach F; Windecker S; Rodondi N; Nanchen D
    Swiss Med Wkly; 2016; 146():w14275. PubMed ID: 26859223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medication Adherence Patterns after Hospitalization for Coronary Heart Disease. A Population-Based Study Using Electronic Records and Group-Based Trajectory Models.
    Librero J; Sanfélix-Gimeno G; Peiró S
    PLoS One; 2016; 11(8):e0161381. PubMed ID: 27551748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study.
    Eagle KA; Kline-Rogers E; Goodman SG; Gurfinkel EP; Avezum A; Flather MD; Granger CB; Erickson S; White K; Steg PG
    Am J Med; 2004 Jul; 117(2):73-81. PubMed ID: 15234641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Community health worker-based intervention for adherence to drugs and lifestyle change after acute coronary syndrome: a multicentre, open, randomised controlled trial.
    Xavier D; Gupta R; Kamath D; Sigamani A; Devereaux PJ; George N; Joshi R; Pogue J; Pais P; Yusuf S
    Lancet Diabetes Endocrinol; 2016 Mar; 4(3):244-253. PubMed ID: 26857999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Length of initial prescription at hospital discharge and long-term medication adherence for elderly patients with coronary artery disease: a population-level study.
    Ivers NM; Schwalm JD; Jackevicius CA; Guo H; Tu JV; Natarajan M
    Can J Cardiol; 2013 Nov; 29(11):1408-14. PubMed ID: 23816280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of adherence to composite therapy after acute coronary syndromes.
    Stabile E; Franzese M; Chianese S; Alfani A; Gerardi D; Colaiori I; Annunziata M; Nappi P; Scalise M; Di Serafino L; Puzone B; Avvedimento M; Leone A; Ilardi F; Piccolo R; Franzone A; Cirillo P; Morisco C; Trimarco B; Esposito G
    J Cardiovasc Med (Hagerstown); 2021 Aug; 22(8):645-651. PubMed ID: 33966020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of Polypharmacy on Adherence to Evidence-Based Medication in Patients who Underwent Percutaneous Coronary Intervention.
    Mohammed S; Arabi A; El-Menyar A; Abdulkarim S; AlJundi A; Alqahtani A; Arafa S; Al Suwaidi J
    Curr Vasc Pharmacol; 2016; 14(4):388-93. PubMed ID: 26517700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of evidence-based cardiac drug therapy on mortality in patients with acute coronary syndrome: Findings from the Gulf COAST registry.
    Al-Zakwani I; Zubaid M; Alsheikh-Ali AA; Almahmeed W; Rashed W
    Cardiovasc Ther; 2018 Dec; 36(6):e12463. PubMed ID: 30079461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in adherence to evidence-based medications in the first year after initial hospitalization for heart failure: observational cohort study from 1994 to 2003.
    Lamb DA; Eurich DT; McAlister FA; Tsuyuki RT; Semchuk WM; Wilson TW; Blackburn DF
    Circ Cardiovasc Qual Outcomes; 2009 May; 2(3):228-35. PubMed ID: 20031842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resource use and costs in high-risk symptomatic peripheral artery disease patients with diabetes and prior acute coronary syndrome: a retrospective analysis.
    Reed Chase M; Friedman HS; Navaratnam P; Heithoff K; Simpson RJ
    Postgrad Med; 2016; 128(2):170-9. PubMed ID: 26788980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adherence to Metformin, Statins, and ACE/ARBs Within the Diabetes Health Plan (DHP).
    Duru OK; Turk N; Ettner SL; Neugebauer R; Moin T; Li J; Kimbro L; Chan C; Luchs RH; Keckhafer AM; Kirvan A; Ho S; Mangione CM
    J Gen Intern Med; 2015 Nov; 30(11):1645-50. PubMed ID: 25944019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multifaceted intervention to improve medication adherence and secondary prevention measures after acute coronary syndrome hospital discharge: a randomized clinical trial.
    Ho PM; Lambert-Kerzner A; Carey EP; Fahdi IE; Bryson CL; Melnyk SD; Bosworth HB; Radcliff T; Davis R; Mun H; Weaver J; Barnett C; Barón A; Del Giacco EJ
    JAMA Intern Med; 2014 Feb; 174(2):186-93. PubMed ID: 24247275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disability, race/ethnicity, and medication adherence among Medicare myocardial infarction survivors.
    Zhang Y; Baik SH; Chang CC; Kaplan CM; Lave JR
    Am Heart J; 2012 Sep; 164(3):425-433.e4. PubMed ID: 22980311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of medications for secondary prevention after coronary bypass surgery compared with percutaneous coronary intervention.
    Hlatky MA; Solomon MD; Shilane D; Leong TK; Brindis R; Go AS
    J Am Coll Cardiol; 2013 Jan; 61(3):295-301. PubMed ID: 23246391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evaluation of hospitalization period and five-year follow-up of patients admitted with acute coronary syndrome following coronary artery bypass graft surgery].
    Can LH; Kayıkçıoğlu M; Yavuzgil O; Kültürsay H; Soydan I
    Turk Kardiyol Dern Ars; 2010 Sep; 38(6):387-92. PubMed ID: 21200116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome.
    Yan AT; Yan RT; Tan M; Huynh T; Soghrati K; Brunner LJ; DeYoung P; Fitchett DH; Langer A; Goodman SG;
    Am Heart J; 2007 Dec; 154(6):1108-15. PubMed ID: 18035083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors, cost, and outcomes of patients with acute coronary syndrome who receive optimal secondary prevention therapy: results from the antiplatelet treatment observational registries (APTOR).
    Zeymer U; Berkenboom G; Coufal Z; Belger M; Sartral M; Norrbacka K; Bakhai A;
    Int J Cardiol; 2013 Dec; 170(2):239-45. PubMed ID: 24225199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longitudinal persistence with secondary prevention therapies relative to patient risk after myocardial infarction.
    Shore S; Jones PG; Maddox TM; Bradley SM; Stolker JM; Arnold SV; Parashar S; Peterson P; Bhatt DL; Spertus J; Ho PM
    Heart; 2015 May; 101(10):800-7. PubMed ID: 25801001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.